My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2025/787 of 24 April 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1,4-dimethylnaphthalene, amidosulfuron, bentazone, bixafen, clomazone, fenoxaprop-P, fludioxonil, fluoxastrobin, flutolanil, fluxapyroxad, gibberellic acid, gibberellins, halauxifen-methyl, mecoprop-P, paraffin oil, penthiopyrad, pirimiphos-methyl, propamocarb, propyzamide, prothioconazole, rimsulfuron, sedaxane and sulfoxaflor

Commission Implementing Regulation (EU) 2025/787 of 24 April 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1,4-dimethylnaphthalene, amidosulfuron, bentazone, bixafen, clomazone, fenoxaprop-P, fludioxonil, fluoxastrobin, flutolanil, fluxapyroxad, gibberellic acid, gibberellins, halauxifen-methyl, mecoprop-P, paraffin oil, penthiopyrad, pirimiphos-methyl, propamocarb, propyzamide, prothioconazole, rimsulfuron, sedaxane and sulfoxaflor

Implementing Regulation (EU) 2025/787 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX 1.    Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (a) in the sixth column, expiration of approval, of row 57, Mecoprop-P, the date is replaced by ‘15 October 2027’; (b) in the sixth column, expiration of approval, of row 125, Rimsulfuron, the date is replaced by ‘15 August 2028’; (c) in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 January 2027’; (d) in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 January 2027’; (e) in the sixth column, expiration of approval, of row 161, Fludioxonil, the date is replaced by ‘30 September 2026’; (f) in the sixth column, expiration of approval, of row 162, Clomazone, the date is replaced by ‘30 September 2026’; (g) in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 January 2027’; (h) in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 March 2027’; (i) in the sixth column, expiration of approval, of row 169, Amidosulfuron, the date is replaced by ‘30 November 2026’; (j) in the sixth column, expiration of approval, of row 182, Fenoxaprop-P, the date is replaced by ‘30 November 2026’; (k) in the sixth column, expiration of approval, of row 187, Flutolanil, the date is replaced by ‘15 June 2026’; (l) in the sixth column, expiration of approval, of row 232, Gibberellic acid, the date is replaced by ‘31 October 2026’; (m) in the sixth column, expiration of approval, of row 233, Gibberellins, the date is replaced by ‘31 October 2026’; (n) in the sixth column, expiration of approval, of row 295, Paraffin oil, the date is replaced by ‘30 November 2026’. 2.    Part B of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (a) in the sixth column, expiration of approval, of row 24, Fluxapyroxad, the date is replaced by ‘31 October 2027’; (b) in the sixth column, expiration of approval, of row 43, Bixafen, the date is replaced by ‘31 October 2027’; (c) in the sixth column, expiration of approval, of row 48, Sedaxane, the date is replaced by ‘31 October 2027’; (d) in the sixth column, expiration of approval, of row 57, Penthiopyrad, the date is replaced by ‘31 October 2027’; (e) in the sixth column, expiration of approval, of row 68, 1,4-Dimethylnaphthalene, the date is replaced by ‘30 November 2027’; (f) in the sixth column, expiration of approval, of row 86, Halauxifen-methyl, the date is replaced by ‘5 January 2028’; (g) in the sixth column, expiration of approval, of row 88, Sulfoxaflor, the date is replaced by ‘18 January 2028’; (h) in the sixth column, expiration of approval, of row 120, Bentazone, the date is replaced by ‘31 October 2027’. 3.    In Part E of the Annex to Implementing Regulation (EU) No 540/2011, in the sixth column, expiration of approval, of row 9, Propyzamide, the date is replaced by ‘30 November 2027’.

Other acts of the same type
Commission Implementing Regulation (EU) 2023/1663 of 21 August 2023 approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (‘Asparago di Cantello’ (PGI))Commission Delegated Regulation (EU) 2023/2070 of 18 August 2023 amending Delegated Regulation (EU) 2016/1675 to add Cameroon and Vietnam to the list of high-risk third countries (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/1643 of 17 August 2023 amending Annexes I and II to Implementing Regulation (EU) 2023/594 laying down special control measures for African swine fever (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/1644 of 17 August 2023 amending Annexes V and XIV to Implementing Regulation (EU) 2021/404 as regards the entries for the United Kingdom and the United States in the lists of third countries authorised for the entry into the Union of consignments of poultry, germinal products of poultry and fresh meat of poultry and game birds (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/1645 of 17 August 2023 approving a non-minor amendment to the specification for a name entered in the register of protected designations of origin and protected geographical indications (‘Los Pedroches’ (PDO))Commission Implementing Regulation (EU) 2023/1653 of 17 August 2023 entering a name in the register of geographical indications for spirit drinks (‘Borzag pálinka’)Regulation (EU) 2023/1678 of the European Central Bank of 17 August 2023 amending Regulation (EU) 2015/534 on reporting of supervisory financial information (ECB/2015/13) (ECB/2023/20)Commission Implementing Regulation (EU) 2023/1773 of 17 August 2023 laying down the rules for the application of Regulation (EU) 2023/956 of the European Parliament and of the Council as regards reporting obligations for the purposes of the carbon border adjustment mechanism during the transitional period (Text with EEA relevance)Commission Delegated Regulation (EU) 2023/2429 of 17 August 2023 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for the fruit and vegetables sector, certain processed fruit and vegetable products and the bananas sector, and repealing Commission Regulation (EC) No 1666/1999 and Commission Implementing Regulations (EU) No 543/2011 and (EU) No 1333/2011Commission Implementing Regulation (EU) 2023/2430 of 17 August 2023 laying down rules concerning checks on conformity to marketing standards for the fruit and vegetables sector, certain processed fruit and vegetable products and the bananas sectorCommission Delegated Regulation (EU) 2023/2464 of 17 August 2023 amending Regulation (EU) No 1308/2013 of the European Parliament and of the Council, as regards marketing standards for eggsCommission Delegated Regulation (EU) 2023/2465 of 17 August 2023 supplementing Regulation (EU) No 1308/2013 of the European Parliament and of the Council as regards marketing standards for eggs, and repealing Commission Regulation (EC) No 589/2008

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next